ChemoMetec A/S
Research ChemoMetec A/S (CHEMM) on Bullrun: market cap DKK 8.48B, P/E 47.8, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCHEMM
- ExchangeCO
- CountryDenmark
- SectorHealthcare
- IndustryMedical Devices
- CurrencyDKK
- Market capDKK 8.48B
- P/E47.8
- Dividend yield1.4%
- Financial periodFY2025
- RevenueDKK 495.57M
- Revenue growth21.5%
- Net incomeDKK 186.41M
- Free cash flowDKK 142.71M
- Gross margin93.9%
Valuation Snapshot
latest market cap is DKK 8.48B; P/E is 47.8; dividend yield is 1.4%.
Peer valuation comparison
Latest P/E is 47.83x versus a Healthcare sector median of 24.46x (95.5% above).
Latest dividend yield is 1.39% versus a Healthcare sector median of 2.11% (34.1% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | DKK 495.57M | DKK 186.41M | DKK 142.71M | 93.9% | 10.71 | DKK 341.85M | DKK 6.40M | DKK 673.36M |
| FY2024 | DKK 407.87M | DKK 136.28M | DKK 85.47M | 90.1% | 7.83 | DKK 296.15M | DKK 4.16M | DKK 565.32M |
| FY2023 | DKK 444.40M | DKK 178.67M | DKK 113.33M | 92.6% | 10.27 | DKK 316.57M | DKK 7.16M | DKK 533.04M |
| FY2022 | DKK 428.39M | DKK 159.47M | DKK 120.94M | 89.7% | 9.16 | DKK 209.03M | DKK 6.79M | DKK 357.21M |
| FY2021 | DKK 427.16M | DKK 159.47M | DKK 137.76M | 90.0% | 9160 | DKK 150.11M | n/a | DKK 264.98M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | DKK 8.48B | 47.8 | 1.4% | 7 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 7 DKK, yield 1.4%.
| Year | Dividends/share |
|---|---|
| FY2025 | 7 DKK |
| FY2024 | 4 DKK |
| FY2023 | 6 DKK |
About ChemoMetec A/S
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ChemoMetec A/S's market cap?
ChemoMetec A/S's market capitalization is DKK 8.48B.
What is ChemoMetec A/S's P/E ratio?
ChemoMetec A/S's price-to-earnings (P/E) ratio is 47.8.
Does ChemoMetec A/S pay a dividend?
ChemoMetec A/S has a dividend yield of 1.4%.
What does ChemoMetec A/S do?
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer.